Case-Based Roundtable Meetings Spotlight April 1, 2021

Molecular Testing Leads to Better Results on Olaparib for Patients With mCRPC

May 05, 2021

Clinical Articles

Findings from the PROfound and National Comprehensive Cancer Network guidelines for molecular testing were reviewed for a discussion on treatment for 60-year-old man with metastatic castration-resistant prostate cancer.